GlycoVaxyn AG Appoints Dr Stanley Plotkin to Supervisory Board
GlycoVaxyn announced that the vaccinologist Dr Stanley A Plotkin has been elected to its Supervisory Board.
Among his achievements, Dr Plotkin developed a vaccine against the rubella virus. This rubella vaccine continues to be in standard use throughout the world today. He is also co-developer of a vaccine against rotavirus and has worked extensively on the development and application of other vaccines, including polio, rabies, varicella, rotavirus and cytomegalovirus.
Dr Plotkin is Emeritus Professor of the University of Pennsylvania and consultant to many vaccine manufacturers. Until 1991, he was Professor of Pediatrics and Microbiology at the University of Pennsylvania and Professor of Virology at the Wistar Institute, whilst simultaneously being Director of Infectious Diseases and Senior Physician at the Children’s Hospital of Philadelphia. In 1991, Dr Plotkin joined the vaccine manufacturer, Pasteur-Mérieux-Connaught (now Sanofi Pasteur), where for seven years he was Medical and Scientific Director.
At various times in his career, Dr Plotkin’s has been chairman of the Infectious Diseases Committee and the AIDS Task Force of the American Academy of Pediatrics, liaison member of the Advisory Committee on Immunization Practices and Chairman of the Microbiology and Infectious Diseases Research Committee of the National Institutes of Health.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
